Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Specialty drugs >  Dermatology drugs >  Calcipotriene

Calcipotriene

Basic information Safety Supplier Related

Calcipotriene Basic information

Product Name:
Calcipotriene
Synonyms:
  • Calcipotrien
  • (1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol
  • (1R,3S,5Z)-5-{2-[(4E)-1-[(2R,3E,5R)-5-CYCLOPROPYL-5-HYDROXYPENT-3-EN-2-YL]-7A-METHYL-HEXAHYDRO-1H-IN
  • Calcipotriene/calcipotriol
  • CALCIPOTRIOL
  • (1s,3s,5z)-5-[(2e)-2-[(1r,3ar,7ar)-1-[(e,2s)-5-cyclopropyl-5-hydroxy-pent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol
  • (1r,3s,5z)-5-[(2e)-2-[1-[(e,2r,5r)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
  • 24-CYCLOPROPYL-(1ALPHA,3BETA,5Z,7E,22E,24S)-9,10-SECOCHOLA-5,7,10(19),22-TETRAENE-1,3,24-TRIOL
CAS:
112828-00-9
MF:
C27H40O3
MW:
412.6
EINECS:
686-849-3
Product Categories:
  • API
Mol File:
112828-00-9.mol
More
Less

Calcipotriene Chemical Properties

CAS DataBase Reference
112828-00-9(CAS DataBase Reference)
More
Less

Calcipotriene Usage And Synthesis

Uses

Antipsoriatic.

Indications

Calcipotriene (calcipotriol) is a synthetic vitamin D3 derivative that is useful for the treatment of patients with moderate plaque psoriasis. Its effects are comparable with those of class II topical steroids, without the associated adverse effects. Its mechanism of action involves both induction of terminal differentiation of keratinocytes and inhibition of keratinocyte production. It should be applied to the face with care, as this region is more susceptible to irritation, burning, and itching, as seen in approximately 10% of patients. Other adverse effects include erythema, peeling, xerosis, dermatitis, or worsening psoriasis in 1% to 10% of patients. Fewer than 1% of patients experience hypercalcemia, atrophy, hyperpigmentation, or folliculitis. Allergic contact dermatitis to calcipotriene has been reported.
Most patients demonstrate improvement after 2 weeks; 70% of patients improve after 8 weeks, with 10% showing complete clearing. It should be avoided in patients with documented impairment in calcium metabolism, hypercalcemia, vitamin D toxicity, or history of renal stones.
Calcipotriene may be used as an adjuvant with psoralens plus ultraviolet A (PUVA) and ultraviolet B (UVB). Pretreatment with or subsequent addition of calcipotriol to PUVA reduces the cumulative doses of UVA needed to achieve >75% reduction in severity and distribution of psoriasis.

Definition

ChEBI: Calcipotriol is a seco-cholestane that is 26,27-cyclo-9,10-secocholesta-5,7,10,22-tetraene carrying additional hydroxy substituents at positions 1, 3 and 24. It is used (as its hydrate) in combination with betamethasone dipropionate, a corticosteroid, for the topical treatment of plaque psoriasis in adult patients. It has a role as a drug allergen and an antipsoriatic. It is a member of cyclopropanes, a secondary alcohol, a triol, a hydroxy seco-steroid and a seco-cholestane.

brand name

Dovonex (Leo).

CalcipotrieneSupplier

Hydragon Pharma Ltd Gold
Tel
021-50215258
Email
market@hypharma.com
Wuhan DKY Technology Co.,Ltd. Gold
Tel
27-81302488 18007166089
Email
info@dkybpc.com
Hubei Lingyan Biotechnology Co., Ltd Gold
Tel
13297019205
Email
2413323910@QQ.COM
Hangzhou Runyan Medical Technology Co., LTD Gold
Tel
13989459766 18112526015
Email
sales@runyanpharma.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com